Avoidable Mortality: The Core of the Global Cancer Divide

Overview of attention for article published in Journal of Global Oncology, August 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 637)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 12 news outlets
twitter: 77 X users

facebook: 2 Facebook pages

Readers on

mendeley: 60 Mendeley

So far, Altmetric has seen 12 news stories from 12 outlets.

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

BioSpace, 12 Mar 2019

/PRNewswire/ -- Lucence Diagnostics, a genomic medicine company focused on personalizing cancer care, today announced a new…

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

BioTech Gate, 12 Mar 2019

/PRNewswire/ -- Lucence Diagnostics, a genomic medicine company focused on personalizing cancer care, today announced a new…

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

CBS8, 12 Mar 2019

SOURCE Lucence Diagnostics SINGAPORE Lucence will be working with Olivier Gevaert Liver cancer is the second leading cause of…

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Morning Star, 12 Mar 2019

/PRNewswire/ -- Lucence Diagnostics, a genomic medicine company focused on personalizing cancer care, today announced a new…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 8 additional news stories.